Tiny signaling hubs in blood vessels point to a new blood pressure target

Researchers have identified tiny signaling hubs in blood-vessel cells that can drive blood pressure in opposite directions. When the balance between these hubs changes, blood vessels may narrow too much, pointing to a possible avenue for more precise treatment.

The finding may help explain why blocking one major chemical signal has not fully captured the complexity of blood-pressure regulation. The same calcium-entry channel can contribute to either vessel tightening or vessel relaxation, depending on where it acts and which proteins are nearby.

A team at the University of Virginia examined arteries, smooth muscle cells, specially bred mice, and samples from people with high blood pressure. The study, published in Circulation in 2022, highlights a potential research target rather than an approved therapy.

Smooth muscle cells wrap around small arteries and help regulate their diameter. When they contract, blood has less space to flow through; when they relax, flow becomes easier and the heart pumps against less resistance.

Calcium plays a central role in how these cells respond to signals. It moves through channels in the cell membrane, but the result depends on the proteins that receive and process that signal, not on calcium producing only one effect.

The researchers focused on channels known as TRPV4. They found two distinct groups of these channels in extremely small regions called nanodomains, which organize different signaling pathways within the same cell type.

One group responded to a chemical signal that causes arteries to constrict. Calcium entering through these channels helped the surrounding muscle tighten, raising resistance and contributing to higher blood pressure.

The other group responded to pressure within the artery. Its calcium signal activated nearby potassium channels, helping the cells relax and countering excessive narrowing, even though the calcium passed through the same broad type of channel.

In high blood pressure, the medical term for hypertension, these opposing effects became out of balance. The constricting pathway became stronger, while the relaxation pathway weakened in the experimental models and human arterial samples studied.

That is why location matters for future treatment. Blocking every channel of this kind could disrupt helpful relaxation signals as well as harmful tightening, while aiming at the abnormal pathway might preserve more normal vessel control.

Much more work is still needed through drug development and medical research. The experiments did not identify a medicine that restores the balance in patients, and they cannot show whether a future targeted treatment would avoid side effects.

The research offers a more detailed look at a familiar mineral signal. Blood-pressure control appears to depend in part on how cells organize calcium messages into tiny local systems, and those systems may provide more selective targets than broadly suppressing the signal itself.

Research journal links

Source: University of Virginia.